UL Solutions Other Non-Current Liabilities increased by 4.3% to $97.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.4%, from $92.00M to $97.00M. Over 2 years (FY 2023 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.00M | $97.00M | $91.00M | $101.00M | $86.00M | $92.00M | $79.00M | $89.00M | $93.00M | $97.00M |
| QoQ Change | — | +4.3% | -6.2% | +11.0% | -14.9% | +7.0% | -14.1% | +12.7% | +4.5% | +4.3% |
| YoY Change | — | — | — | — | -7.5% | -5.2% | -13.2% | -11.9% | +8.1% | +5.4% |